“bristol-myers-squibb” Archives

in
Entry Author Date Location
Lacking Details, Roche Touts Drug Combo’s Success in Lung Cancer 11/20/17 San Francisco
With $25M, Torque Aims for a More Targeted Cell Therapy for Cancer 11/14/17 Boston
Bio Roundup: Barron Joins GSK, Sage Bounces Back, Valeant Dumps Addyi 11/10/17 National
Five Prime Shares Dive on Latest Hiccup For Cancer Immunotherapy Combos 11/07/17 San Francisco
PathAI Grabs $11M to Build A.I. Tools for Pathology 11/02/17 Boston
Bio Roundup: Kite’s CAR-T Approved, Obamacare Fix & Lilly mRNA Deal 10/20/17 National
Bio Roundup: Graham-Cassidy, Axovant Fail, SpringWorks Launches & More 09/29/17 National
San Antonio Spends $200,000 to Get New Biotech Pelican Therapeutics 09/25/17 Texas
Bio Roundup: Phase 3 Fails, Shkreli Jailed, Moderna Flip-Flops & More 09/15/17 National
Bio Roundup: RNAi Drama, Immunotherapy Data, Lasker Winners & More 09/08/17 National
To Be More Than Quick Splash, Gilead’s CAR-T Purchase Faces Hurdles 08/28/17 San Francisco
Bio Roundup: Frazier v. Trump, Data Dumps, New York Steps & More 08/18/17 National
Latest Immunotherapy Setback: Bristol Drugs Stumble in Kidney Cancer 08/16/17 New York
IFM Gets $300M Bristol Buyout, Plans Second Strike With New Spinout 08/03/17 Boston
Bio Roundup: GOP Drama, Immunotherapy Setbacks, Pharma Revamps 07/28/17 National
Immunotherapy Shakeup: AstraZeneca Inks Merck Deal as Drug Combo Fails 07/27/17 National
Bio Roundup: BCRA Fireworks, Shkreli Muzzled, Endo Pulls Drug & More 07/07/17 National
In a Myeloma Setback, Merck Halts Studies Due to Patient Deaths 06/12/17 New York
Mersana Plans IPO to Finance Clinical Trials for Breast Cancer Drug 06/02/17 Boston
Bio Roundup: Skinny Cuts, Genomic Approvals, Unfrozen FDA & More 05/26/17 National
FDA Landmark Nod: Cancer Drug To Match Tumor Genes, Not Tissue Type 05/23/17 National
Not Resting on Hemophilia Biz, Bioverativ Pays $400M For True North 05/23/17 Boston
With Latest Deal, Biogen Bets $120M on Remedy Pharma Stroke Drug 05/15/17 Boston
Merck Immunotherapy Drug Notches Another FDA Win in Lung Cancer 05/11/17 New York
Genentech Drug Fails to Beat Chemo in Treating Advanced Bladder Cancer 05/10/17 San Francisco
With $75M Haul, Ovid Continues Flurry of Biotech IPOs 05/04/17 New York
Bio Roundup: CRISPR Appeal, Bristol Deals, Stock Pumping & More 04/14/17 National
Bristol Flips Remnants of Adnexus, iPierian to Roche, Biogen For $470M 04/13/17 New York
With Ovid IPO, Ex-Teva CEO Levin Pitches Neuro Drug Plan to Wall Street 04/11/17 New York
AACR Review: Biden Fired Up, Incyte Doubles Up, BMS Up And Down 04/06/17 National
Page 1 of 14 next page »